Blood Transfusion Market Size, Share & Trends Analysis | Global | 2024-2030 | MedCore

  • Year: 2024
  • Scope: 10 Years
  • Region: Global
  • Type: MedCore

Product Description

Overall, the global blood transfusion set market was valued at $480.1 million in 2023, a 3.5% decrease from $464.1 million in 2022. This is expected to increase over the forecast period at a CAGR of 3.0% to reach $591 million. Currently, the global blood transfusion market is dominated by Becton Dickinson (BD), Baxter, and ICU Medical.

Throughout this medical market research, we analyzed over 15 blood transfusion companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.

DATA TYPES INCLUDED

  • Unit SalesAverage Selling PricesMarket Value & Growth Trends
  • Forecasts Until 2030, and Historical Data to 2020
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • COVID19 Impact
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

GLOBAL BLOOD TRANSFUSION MARKET INSIGHTS global blood transfusion market

As chronic illnesses such as cancer, cardiovascular diseases, and blood disorders continue to rise in frequency, the necessity for regular blood transfusions as a critical component of treatment escalates. As the occurrence of these ailments increases, so does the requirement for blood transfusion kits, serving as a lifeline for individuals confronting these formidable health challenges. The escalating prevalence of chronic diseases emphasizes the pivotal function of blood transfusion kits in delivering vital care and assistance to those who require it, charting a course towards enhanced healthcare results.

GLOBAL BLOOD TRANSFUSION MARKET SHARE INSIGHTSglobal blood transfusion market

Becton Dickinson (BD) held the top position among competitors in the blood transfusion device market. BD provided a range of blood IV sets, available in both pump-based and gravity-based options, featuring a 180-µm filter, a pressure pump, a needleless connector, and male Luer lock adapters. These sets were specifically tailored for use with BD’s Alaris brand of infusion pumps. BD’s presence in the IV set market was significant, and in 2015, the company acquired its infusion therapy products from CareFusion, further solidifying its standing in the industry.

Baxter occupied the second-ranking position in the blood transfusion device market. The company offered a diverse array of blood collection and administration sets, encompassing standard blood in-line filters, Y-sites, male Luer lock injection adapters, and a pressure pump. Baxter held a prominent position in both the IV set and infusion pump markets, leveraging its strong foothold to drive sales of blood sets. Their product lineup included dual-chamber and single-chamber devices.

ICU Medical, the third-leading competitor in the blood transfusion device market, particularly excelled in North America. The company boasted an extensive range of products and disposables within its infusion therapy portfolio, which was further expanded through the acquisition of Smiths Medical. ICU Medical provided transfusion sets compatible with both gravity and infusion pumps. Additionally, they offered three distinct blood collection and administration tubing options, along with associated accessories, as part of their Saf-T Wing™ product line.

MARKET SEGMENTATION SUMMARY

  • Blood Transfusion Market

Global Research Scope Summary

Report AttributeDetails
RegionsNorth America (Canada, United States)
Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela)
Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.)
Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine)
Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam)
Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year2023
Forecast2024-2030
Historical Data2020-2023
Quantitative CoverageMarket Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative CoverageCOVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data SourcesPrimary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

 

FREE Sample Report

Blood Transfusion Device Market
11.1 Executive Summary
11.1.1 Global Blood Transfusion Device Market Overview
11.1.2 Competitive Analysis
11.1.3 Regions Included
11.2 Introduction
11.3 Market Analysis and Forecast
11.4 Drivers and Limiters
11.4.1 Market Drivers
11.4.2 Market Limiters
11.5 Competitive Market Share Analysis
Becton Dickinson
Baxter
ICU Medical
Fresenius Kabi
B. Braun
CODAN
Fannin
Others
Chart 11‑1: Blood Transfusion Device Market, Global, 2023 & 2030
Chart 11‑2: Blood Transfusion Device Units Sold, Global, 2023
Chart 11‑3: Blood Transfusion Device Market, Global, 2020 – 2030
Chart 11‑4: Leading Competitors, Blood Transfusion Device Market, Global, 2023
Figure 11‑1: Blood Transfusion Device Regions Covered, Global (1 of 2)
Figure 11‑2: Blood Transfusion Device Regions Covered, Global (2 of 2)
Figure 11‑3: Blood Transfusion Device Market, Global, 2020 – 2030
Figure 11‑4: Units Sold by Region, Blood Transfusion Device Market, Global, 2020 – 2030
Figure 11‑5: Average Selling Price by Region, Blood Transfusion Device Market, Global, 2020 – 2030 (US$)
Figure 11‑6: Market Value by Region, Blood Transfusion Device Market, Global, 2020 – 2030 (US$M)
Figure 11‑7: Leading Competitors, Blood Transfusion Device Market, Global, 2023

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

This global market research spans over 70 countries and includes the global market for blood transfusion devices.

  • 2024
  • 10 Years
  • Global
  • MedCore
0
    0
    Your Cart
    Your cart is emptyReturn to Report Library